Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Hollestein

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|June 16, 2020
Survival is excellent for most patients with thin melanoma, but patients may die from thin melanomaL M Hollestein, T Nijsten
The British Journal of Dermatology|April 17, 2014
The association between beta-blockers and melanoma survival: evidence of absence or absence of evidence?L M Hollestein, T Nijsten
Journal of the European Academy of Dermatology and Venereology : JEADV|October 25, 2025
The quest for missing risk factors to predict melanomaM Wakkee, L M Hollestein
The British Journal of Dermatology|July 16, 2015
Guidelines for statistical reporting in the British Journal of DermatologyL M Hollestein, T Nijsten
The British Journal of Dermatology|July 5, 2021
Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?L M Hollestein, S Arnspang Pedersen
The British Journal of Dermatology|January 10, 2018
Missing data in clinical research: an integrated approachL M Hollestein, J R Carpenter
European Journal of Cancer (Oxford, England : 1990)|February 21, 2012
Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008L M Hollestein, E de Vries, T Nijsten
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2018
Treatment and frequency of follow-up of BCC patients in the NetherlandsE de Vries, Y Misirli, T Nijsten, et al.
Skin Health and Disease|June 6, 2022
What are the most important factors in basal cell carcinoma follow-up care? The perspective of patientsS van Egmond, M Lugtenberg, E C Noels, et al.
The British Journal of Dermatology|May 21, 2016
Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner dataE A Dowlatshahi, L M Hollestein, R M C Herings, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|June 16, 2020
Survival is excellent for most patients with thin melanoma, but patients may die from thin melanomaL M Hollestein, T Nijsten
The British Journal of Dermatology|April 17, 2014
The association between beta-blockers and melanoma survival: evidence of absence or absence of evidence?L M Hollestein, T Nijsten
Journal of the European Academy of Dermatology and Venereology : JEADV|October 25, 2025
The quest for missing risk factors to predict melanomaM Wakkee, L M Hollestein
The British Journal of Dermatology|July 16, 2015
Guidelines for statistical reporting in the British Journal of DermatologyL M Hollestein, T Nijsten
The British Journal of Dermatology|July 5, 2021
Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?L M Hollestein, S Arnspang Pedersen
The British Journal of Dermatology|January 10, 2018
Missing data in clinical research: an integrated approachL M Hollestein, J R Carpenter
European Journal of Cancer (Oxford, England : 1990)|February 21, 2012
Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008L M Hollestein, E de Vries, T Nijsten
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2018
Treatment and frequency of follow-up of BCC patients in the NetherlandsE de Vries, Y Misirli, T Nijsten, et al.
Skin Health and Disease|June 6, 2022
What are the most important factors in basal cell carcinoma follow-up care? The perspective of patientsS van Egmond, M Lugtenberg, E C Noels, et al.
The British Journal of Dermatology|May 21, 2016
Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner dataE A Dowlatshahi, L M Hollestein, R M C Herings, et al.
Pageof 4